Seeking Alpha

Clene Provides Update on ALS Clinical Development Meeting With FDA

SALT LAKE CITY, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical ...
GEN

Biological Complexity of ALS to Be Addressed by the Development of New Stem Cell Models

Degradation of motor neurons, conceptual computer illustration. Motor neuron diseases are a group of neurodegenerative disorders Amyotrophic lateral sclerosis (ALS) is the most common of the motor ...
WAVY-TV

BrainStorm to Present Biomarker Insights Supporting NurOwn's Mechanism of Action and Clinical Impact at the 2025 ALS Drug Development Summit

NEW YORK, May 6, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced its participation in ...
RAPS

Final ALS Drug Development Guidance Coming Soon

Acting US Food and Drug Administration (FDA) Commissioner Ned Sharpless on Thursday announced that the agency would finalize guidance on developing treatments for amyotrophic lateral sclerosis (ALS) ...
KOIN 6

Financing Innovation: Proposal for Novel Adaptive Platform Trial Fund Offers New Model for ALS Drug Development

Cambridge, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- A team of researchers from the MIT Sloan School of Management, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), ...
Nasdaq

Athira Pharma Reports Positive Phase 1 Trial Results for ATH-1105, Supporting Continued Development for ALS Treatment

Athira Pharma, Inc. has announced favorable results from a Phase 1 clinical trial of its drug candidate ATH-1105, which targets neurodegenerative diseases like amyotrophic lateral sclerosis (ALS). The ...
EurekAlert!

Answer ALS launches AI drug development collaboration with GATC Health, Pennington Biomedical Research Center, and Tulane to advance ALS treatment discovery

NEW ORLEANS, July 22, 2025 — Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative ...
KXAN

The ALS Association Awards 8 Hoffman ALS Clinic Development & Capacity Awards to Expand Access to Life-Enhancing Multidisciplinary ALS Care

Funding aims to bring high quality ALS care closer to home and more accessible for people living with ALS nationwide "Thanks to this transformational gift, we are able to support clinical programs ...
News Medical

Event guide: The 5th ALS Drug Development Summit

After a period of clinical recalibration, the ALS and FTD field is regaining momentum, driven by a deeper biological understanding, more refined translational strategies, and continued industry ...
Hoodline

ALS Lab Locks In Watertown Deal As Arsenal Yards Lands New Research Heavyweight

According to the Boston Business Journal, ALS Therapy Development Institute has agreed to a 33,310-square-foot lease at 200 ...
EurekAlert!

Answer ALS Launches AI drug development collaboration with Tulane, Pennington Biomedical Research Center and GATC Health to advance ALS treatment discovery

Pennington Biomedical’s Dr. Jeff Keller and Dr. Aron Culotta of Tulane to lead collaboration of AI researchers, neuroscientist and drug developers Answer ALS is proud to announce the launch of a ...